Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (63)
Human immunodeficiency virus (HIV) (16)
Tuberculosis (TB) (16)
SDG-03: Good health and well-being (9)
Multidrug-resistant (MDR) (7)
Mycobacterium tuberculosis (MTB) (6)
Sexually transmitted infection (STI) (6)
Drug resistance (5)
Whole genome sequencing (WGS) (4)
Antimicrobial resistance (AMR) (3)
Colistin resistance (3)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Extensively drug-resistant tuberculosis (XDR-TB) (3)
Mycoplasma genitalium infection (3)
Public health (3)
Rifampicin-resistant tuberculosis (3)
Transmission (3)
Women (3)
Adolescent girls and young women (AGYW) (2)
Africa (2)
Antiretroviral therapy (ART) (2)
Chlamydia trachomatis (2)
Drug-resistant tuberculosis (DR-TB) (2)
Enterobacteriaceae (2)
Enterohaemorrhagic Escherichia coli (EHEC) (2)
Epidemics (2)
HIV prevention (2)
Infection (2)
Lymphogranuloma venereum (LGV) (2)
Meningitis (2)
Mobilome (2)
Molecular epidemiology (2)
Multidrug-resistant tuberculosis (MDR-TB) (2)
Mycobacterium tuberculosis (2)
Neisseria gonorrhoeae infection (2)
Patients (2)
Phylogenomics (2)
Polymerase chain reaction (PCR) (2)
Pre-exposure prophylaxis (PrEP) (2)
Pregnant women (2)
Pulsed-field gel electrophoresis (PFGE) (2)
Resistome (2)
SDG-02: Zero hunger (2)
Sub-Saharan Africa (SSA) (2)
Treatment (2)
Urinary tract infection (UTI) (2)
Vaccine-induced seropositivity (VISP) (2)
Whole-genome sequencing (WGS) (2)
Women living with HIV (WLHIV) (2)
24-loci MIRU-VNTR typing (1)
Acinetobacter baumannii (1)
Acinetobacter baumannii complex (ABC) (1)
Acquired drug resistance (1)
Acquired immune deficiency syndrome (AIDS) (1)
Activity space (1)
Adult gonorrhea (1)
Agarose (1)
Age (1)
All-oral treatment (1)
AmpC (1)
Anaerobic growth (1)
Animals (1)
Antenatal care (ANC) (1)
Antibiotic (1)
Antibiotic sensitivity (1)
Antibiotics (1)
Antifungal susceptibility (1)
Antimicrobial resistance (1)
Antimicrobial susceptibility (1)
Antimicrobial susceptibility testing (AST) (1)
Antintiretroviral therapy (ART) (1)
Antiretroviral (ARV) (1)
Anyplex™ plus (1)
Attributable risk (1)
Automation (1)
Azithromycin (AZM) (1)
Bacillus Calmette–Guerin (BCG) (1)
Bacteria (1)
Bacteria (microorganisms) (1)
Bacterial cell wall (1)
Bacterial disease (1)
Bacterial genome (1)
Bacterial strain (1)
Bacterial virulence (1)
Bacterium isolate (1)
BCG disease (1)
Bedaquiline (1)
Bedaquiline-containing regimen (1)
Bias analysis (1)
Biodiversity (1)
blaOXA-23-like (1)
Blindness (1)
Blood cultures (1)
Burkina Faso (BF) (1)
Catheter-related bloodstream infections (1)
Catheter-related bloodstream infections (CRBSI) (1)
Catheter-related infections (1)
Cell adhesion (1)
Central line-associated bloodstream infections (1)